277 related articles for article (PubMed ID: 31818145)
21. Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
Lin TK; Yeh TH; Hsu PW; Chuang CC; Tu PH; Chen PY; Jung SM; Wei KC; Huang YC
World Neurosurg; 2017 Jul; 103():550-556. PubMed ID: 28363832
[TBL] [Abstract][Full Text] [Related]
22. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E
Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
Min M; Lin L; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):110-6. PubMed ID: 22780928
[TBL] [Abstract][Full Text] [Related]
24. Diffuse large B-cell lymphoma of the central nervous system presenting as "lymphomatosis cerebri" and dementia in elderly man: Case report and review of the literature.
Kerbauy MN; Pasqualin DDC; Smid J; Iquizli R; Kerbauy LN; Nitrini R; Ribas GC; Neder L; Hamerschlak N
Medicine (Baltimore); 2019 Feb; 98(6):e14367. PubMed ID: 30732171
[TBL] [Abstract][Full Text] [Related]
25. Primary Central Nervous System Lymphoma in a Patient with Down Syndrome.
Shibata A; Yamaguchi F; Sasaki K; Yokobori S; Morita A
J Nippon Med Sch; 2023 Sep; 90(4):346-350. PubMed ID: 35644559
[TBL] [Abstract][Full Text] [Related]
26. Primary central nervous system lymphoma.
Bhagavathi S; Wilson JD
Arch Pathol Lab Med; 2008 Nov; 132(11):1830-4. PubMed ID: 18976024
[TBL] [Abstract][Full Text] [Related]
27. Primary central nervous system lymphoma: Novel precision therapies.
Mondello P; Mian M; Bertoni F
Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
[TBL] [Abstract][Full Text] [Related]
28. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract][Full Text] [Related]
29. Primary CNS lymphoma.
Phillips EH; Fox CP; Cwynarski K
Curr Hematol Malig Rep; 2014 Sep; 9(3):243-53. PubMed ID: 24969265
[TBL] [Abstract][Full Text] [Related]
30. Treatment outcome and prognostic factors in PCNSL.
Niparuck P; Boonsakan P; Sutthippingkiat T; Pukiat S; Chantrathammachart P; Phusanti S; Boonyawat K; Puavilai T; Angchaisuksiri P; Ungkanont A; Chuncharunee S; Atichartakarn V
Diagn Pathol; 2019 Jun; 14(1):56. PubMed ID: 31189479
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
[TBL] [Abstract][Full Text] [Related]
32. Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.
Sethi TK; Reddy NM
Leuk Lymphoma; 2019 Jan; 60(1):6-18. PubMed ID: 29741421
[TBL] [Abstract][Full Text] [Related]
33. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
[TBL] [Abstract][Full Text] [Related]
34. Perforation in an intestinal malignant lymphoma case.
Imataki O; Shiroshita K; Uchida S; Kida J; Akamoto S; Uemura M
BMC Res Notes; 2016 Jun; 9():308. PubMed ID: 27297406
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
36. [Primary central nervous system malignant lymphoma originating from the cerebellum and extending along the lower cranial nerves].
Sasahara A; Kawamata T; Kubo O; Okami N; Kawamura H; Hori T
No Shinkei Geka; 2000 Oct; 28(10):879-83. PubMed ID: 11070908
[TBL] [Abstract][Full Text] [Related]
37. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Wong ET; Tishler R; Barron L; Wu JK
Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
[TBL] [Abstract][Full Text] [Related]
38. Advances in Primary Central Nervous System Lymphoma.
Patrick LB; Mohile NA
Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
[TBL] [Abstract][Full Text] [Related]
39. An atypical presentation of primary central nervous system lymphoma: A case report.
Yuen CA; Mastrianni J; Ali S; Pytel P; Park DM; Rezania K
Medicine (Baltimore); 2020 Sep; 99(38):e22062. PubMed ID: 32957327
[TBL] [Abstract][Full Text] [Related]
40. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
